Characteristics of HIV antiretroviral treatments, access and adherence in an ethnically diverse sample of men who have sex with men

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

Volumn 15, Issue 1, 2003, Pages 89-102

  Halkitis, Perry N ^a   Parsons, J T ^b   Wolitski, R J ^b   Remien, R H ^b  

^a NEW YORK UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; ANTIVIRUS AGENT; CD4 ANTIGEN; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADULT; ARTICLE; COPING BEHAVIOR; ETHNIC GROUP; HEALTH CARE ACCESS; HEALTH INSURANCE; HEALTH STATUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; SELF REPORT; SUBSTANCE ABUSE; TREATMENT OUTCOME; VIRUS INFECTION; VIRUS LOAD;

ADULT; AFRICAN AMERICANS; ANTI-HIV AGENTS; CROSS-SECTIONAL STUDIES; DRUG THERAPY, COMBINATION; EUROPEAN CONTINENTAL ANCESTRY GROUP; HEALTH SERVICES ACCESSIBILITY; HISPANIC AMERICANS; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; MALE; MULTIVARIATE ANALYSIS; NEW YORK CITY; PATIENT COMPLIANCE; PROTEASE INHIBITORS; REVERSE TRANSCRIPTASE INHIBITORS; SAN FRANCISCO;

EID: 0037307960     PISSN: 09540121     EISSN: None     Source Type: Journal    
DOI: 10.1080/095401221000039798     Document Type: Article

References (54)

1. ANGEL, S., KRAVCIK, E., BALASKAS, P. YEN, A.D., BADLEY, D., CAMERON, W. & HU, Y.-W. (2000). Documentation of HIV-1 superinfection and acceleration of disease progression. Paper presented at the 7th Conference on Retroviruses and Opportunistic Infections, San Francisco, CA, February.
2. ARNSTEN, J., DEMAS, P., GOUREVITCH, M., BUONO, D., FARZADEGAN, H. & SCHOENBAUM, E. (2000). Adherence and viral load in HIV-infected drug users: comparison of self-report and medication event monitors (MEMS). Paper presented at the 7th Conference on Retroviruses and Opportunistic Infections, San Francisco, CA, February.
3. BANGSBERG, D.R., HECHT, F.M., CHARLEBOIS, E.D., ZOLOPA, A.R., HOLODNTY, M., SHEINER, L., BAMBERGER, J.D., CHESNEY, M.A. & Moss, A. (2000). Adherence to protease inhibitors, HIV-viral load, and development of drug resistance in an indigent population. AIDS, 14, 357-366.
4. BING, E.G., KILBOURNE, A.M., BROOKS, R.A., LAZARUS, E.F. & SENAK, M. (1999). Protease inhibitor use among a community sample of people with HIV. Journal of Acquired Immune Deficiency Syndrome and Human Retrovirology, 20, 474-480.
5. CARPENTER, C.C., FISCHL, M.A., HAMMER, S.M., JACOBSEN, D.M., KATZENSTEIN, D.A., MONTANER, J.S., RICHMAN, D.D., SAAG, M.S., SCHOOLEY, R.T., THOMPSON, M.A., VELLA, S, YENI, P.G. & VOLBERDING, P.A. (1997). Antiretroviral therapy for HIV infection in 1997: updated recommendation of the International AIDS Society - USA Panel. Journal of the American Medical Association, 227, 1062-1969.
6. CATZ, S.L., KELLY, J.A., BOGART, L.M., BENOTSCH, E.G. & MCAULIFFE, T.A. (2000). Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease. Health Psychology, 19, 124-133.
7. CATZ, S.L. & MCCLURE, J.B. (1998). HIV outpatient adherence: relation of disease status to appointment-keeping. Poster presented at the 12th World AIDS Conference, Geneva, Switzerland.
8. CENTERS FOR DISEASE CONTROL AND PREVENTION (2000a). HIV surveillance supplemental report: AIDS cases diagnosed in 1997 and 1998 by sex, race/ethnicity, age at diagnosis, and risk exposure, 5(3), 4-5. Atlanta: CDC.
9. CENTERS FOR DISEASE CONTROL AND PREVENTION (2000b). HIV/AIDS among racial/ethnic minority men who have sex with men - United States, 1989-1998. Morbidity and Mortality Weekly Report, 49, 4.
10. CHESNEY, M., FOLKMAN, S. & CHAMBERS, D. (1996). Coping effectiveness training for men living with HIV: preliminary findings. International Journal of STD & AIDS, 7 (Suppl. 2), 75 - 82.
11. CHESNEY, M.A., ICKOVICS, J.R., CHAMBERS, D.B., GIFFORD, A.L., NEIDIG, J., ZWICKL, B. & WU, A.W. (2000). Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG Adherence Instruments. AIDS Care, 12 (3), 255-266.
12. COOK, R.L., SEREIKA, S.M., HUNT, S.C., WOODWARD, W.C., ERLEN, J.A. & CONIGLIARO, J. (2001). Problem drinking and medication adherence among persons with HIV infection. Journal of General Internal Medicine, 16, 83-88.
13. CRESPO-FIERO, M. (1997). Compliance/adherence and care management in HIV disease. Journal of the Association of Nurses in AIDS Care, 8(4), 43-54.
14. DEMAS, P., SCHOENBAUM, E.E., HIRKY, E.A., WILLS, T.A., DOLL, L.S., HARTEL, D.M. & KLEIN, R.S. (1998). The relationship of HIV treatment acceptance and adherence to psychosocial factors among injecting drug users. AIDS and Behavior, 2, 283-292.
15. DEMASI, R., TOLSON, J., PHAM, S. CAPUANO, G., GRAHAM, N., FISHER, R., SHAEFER, M. & ERON, J. (1999). Self-reported adherence to HAART and correlation with HIV RNA: initial results with the Patient Medication Adherence Questionnaire. Paper presented at the 6th Conference on Retroviruses and Opportunistic Infections, Chicago, IL, February.
16. DEROGATIS, L. & MELISARATOS, N. (1983). Brief Symptom Inventory (BSI): an introductory report. Psychological Medicine, 13, 595-605.
17. DIAZ, M.J., CISEK, T.J., NIONNE, B. & TOTTENHAM, N. (1999). Behavior practices regarding combination therapies for HIV/AIDS. Journal of Sex Education & Therapy, 24, 81-88.
18. ELDRED, L.J., WU, A.W., CHAISSON, R.E. & MOORE, R.D. (1998). Adherence to antiretroviral and pneumocystis prophylaxis in HIV disease. Journal of Acquired Immune Deficiency Syndrome and Human Retrovirology , 18, 117-125.
19. FISCHER, D.G. & FICK, C. (1993). Measuring social desirability: short forms of the Marlowe-Crowne Social Desirability Scale. Educational & Psychological Measurement, 53, 417-424.
20. GELETKO, S.M., SEGARRA, M., MAYER, K.H., FIORE, T.C., BETTANCOURT, F.A., FLANIGAN, T.P. & DUDLEY, M.N. (1996). Electronic compliance assessment of antifungal prophylaxis for human immunodeficiency virus-infected women. Antimicrobial Agents & Chemotherapy, 40, 1338-1341.
21. GOETZ, M.B. & ROSSMAN, B.L. (1998, June). Evaluation of predictors of adherence in HIV-infected patients receiving combination anti-retroviral therapy. Poster presented at the 12th World AIDS Conference, Geneva, Switzerland.
22. HALKITIS, P.N. (1998). Advances in treatment of HIV disease: complexities of adherence and complications for prevention, The Health Psychologist, 20(1), 6-7, 14.
23. HALKITIS, P.N. & KIRTON, C. (1999). Self-strategies as means of enhancing adherence to HIV antiretroviral therapies: a Rogerian approach. Journal of the New York State Nurses Association, 30(2), 22-27.
24. HALKITIS, P.N. & WILTON, L. (1999). Beyond complacency: the effects of treatment advances on HIV transmission. Focus: A Guide to AIDS Research and Counseling, 14(5), 1-5.
25. HAUBRICH, R.H., LITTLE, S.J., CURRIER, J.S., FORTHAL, D.N., KEMPER, C.A., BEALL, G.N., JOHNSON, D., DUBE, M.P., HWANG, J.Y., MCCUTCHAN, A. & THE CALIFORNIA COLLABORATIVE TREATMENT GROUP (1999). The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. AIDS, 13, 1099-1107.
26. HECHT, F.M., COLFAX, G., SWANSON, M. & CHESNEY, M.A. (1998). Adherence and effectiveness of protease inhibitors in clinical practice. Paper presented at the 5th Conference on Retrovirus and Opportunistic Infections. Chicago.
27. HECHT, F.M., GRANT, R., PETROPOULOS, C., DILLON, B., CHESNEY, M.A., TIAN, H., HELLMANN, N.S., BANDRAPALLI, N.I., DIGILIO, L., BRANSON, B. & KAHN, J.O. (1998). Sexual transmission of HIV-1 variant resistant to multiple reverse-transcriptase and protease inhibitors. New England Journal of Medicine, 339, 307-343.
28. HO, D.D., NEUMAN, A.U., PERELSON, A.S., CHEN, W., LEONARD, J.M. & MARKOWITZ, M. (1995). Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature, 373 (6510), 123-126.
29. HOLZEMER, W.L., CROLESS, I.B., NOKES, K.M., TURNER, J.G., BROWN, M.A., POWELL-COPE, G.M., INOUYE, J., HENRY, S.B., NICHOLAS, P.K. & PORTILLO, C.J. (1999). Predictors of self-reported adherence in persons living with HIV disease. AIDS Patient Care & STDs , 13, 185-197.
30. ICKOVICS, J.R. & MEISLER, A.W. (1996). Adherence in AIDS clinical trials: a framework for clinical research and clinical care. American Journal of Medicine, 92, 492-502.
31. KALICHMAN, S.C., CATZ, S. & RAMACHANDRAN, B. (1999). Barriers to HIV/AIDS treatment and treatment adherence among African American adults with disadvantaged education. Journal of the National Medical Association, 91, 439-446.
32. KALICHMAN, S.C., RAMACHANDRAN, B. & CATZ, S. (1999). Adherence to combination antiretroviral therapies in HIV patients of low health literacy. Journal of General International Medicine, 14, 267-273.
33. KASTRISSIOS, H., SUAREZ, J.R., KATZENSTEIN, D., GIRARD, P., SHEINER, L.B. & BLASCHKE, T.F. (1998). Characterizing patterns of drug-taking behavior with a multiple drug regimen in an AIDS clinical trial. AIDS, 12, 2295-2303.
34. KILBY, J.M., SAAG, M.S., GOEPFERT, P.A., HOCKETT, R.D., SAHA, B.K. & BUCY, R.O. (2000). Significant delay in plasma VRNA rebound during a scheduled treatment interruption in HIV-1 chronically infected patients previously on effective therapy. Paper presented at the 7th Conference on Retroviruses and Opportunistic Infections, San Francisco, CA, February.
35. KNOBEL, H., CARMONA, A., LOPEZ, J.L., GIMENO, J.L., SABALLS, P., GONZALEZ, A., GUELAR, A. & DIAZ, A. (1999). Adherence to very active antiretroviral treatment: impact of individualized assessment. Enfermedades infecciosas y microbiologia clinica, 17(2), 78-81.
36. LOW-BEER, S., YIP, B., O'SHAUGHNESSY, M.V., HOGG, R.S. & MONTANER, J.S.G. (2000). Adherence to triple therapy and viral load response. Journal of Acquired Immune Deficiency Syndrome, 23(4), 360.
37. MAHER, K., KLIMAS, N., FLETCHER, A., COHEN, V., MAGGIO, C.M., TRIPLETT, J., VALENZUELA, R. & DICKINSON, G. (1999). Disease progression, adherence, and response to protease inhibitor therapy for HIV infection in an urban veterans affairs medical center. Journal of Acquired Immune Deficiency Syndrome, 22, 358-363.
38. MEHTA, M., MOORE, R.D. & GRAHAM, N.M.H. (1997). Potential factors affecting adherence with HIV therapy. AIDS, 11, 1665-1670.
39. MELBOURNE, K.M., GELETKO, S.M., BROWN, S.L., WILLEY-LESSNE, C., CHASE, S. & FISHER, A. (1999). Medication adherence in patients with HIV infection: a comparison of two measurement methods. AIDS Reader, 9, 329-338.
40. MICHAELS, S.H., CLARK, R. & KISSINGER, P. (1999). Incidence and spectrum of AIDS-defining illnesses among persons treated with antiretroviral drugs. Clinical Infectious Diseases, 29, 468-469.
41. MISENER, T.R. & SOWELL, R.L. (1998). HIV infected women's decisions to take antiretrovirals. Western Journal of Nursing Research, 20, 431-447.
42. MONTANER, J.S., HARRIS, M., MO, T. & HARRIGAN, P.R. (1998). Rebound of plasma HIV viral load following prolonged suppression with combination therapy. AIDS, 12, 1398-1399.
43. MOSTASHARI, F., RILEY, E., SELWYN, P.W. & ALTICE, F.L. (1998). Acceptance and adherence with antiretroviral therapy among HIV-infected women in a correctional facility. Journal of Acquired Immune Deficiency Syndrome and Human Retrovirology, 18, 341-348.
44. PATERSON, D.L., SWINDELLS, S., MOHR J., BRESTER, M., VERGIS, E.N., SQUIER, C., WAGENER, M.M. & SINGH, N. (2000). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine, 133(1), 21-30.
45. RABKIN, J.G. & CHESNEY, M. (1999). Treatment adherence in HIV medications: the Achilles heel of new therapeutics. In: OSTROW, D.G. & KALICHMAN, S.C. (Eds), Psychosocial and public health impacts of new HIV therapies (pp. 61-79). New York: Kluwer.
46. ROLAND, M.E. (1998). Antiviral adherence dilemmas. Focus, 13 (3), 1-4.
47. RUSSELL, D.W. (1996). UCLA Loneliness Scale (version 3): reliability, validity, and factor structure. Journal of Personality Assessment, 66 (1), 20-40.
48. SINGH, N., BERMAN, S.M., SWINDELLS, S., JUSTIS, J.C., MOHR, J.A., SQUIER C. & WAGENER, N.M. (1999). Adherence of human immunodeficiency virus-infected patients to antiretroviral therapy. Clinical Infectious Diseases, 29, 824-830.
49. SINGH, N., SQUIER, C., SIVEK, C., WAGENER, M., NGUYEN, M.H. & Yu, V.L. (1996). Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: prospective assessment with implications for enhancing compliance. AIDS Care, 8, 261-269.
50. SORVILLO, F., KERNDT, P., ODEM, S., CASTILLON, M., CARRUTH, A. & CONTRERAS, R. (1999). Use of protease inhibitors among persons with AIDS in Los Angeles County. AIDS Care, 11, 147-155.
51. STALL, R., HOFF, C., COATES, T., PAUL, J., PHILLIPS, K., EKSTRAND, M., KEGELES, S., CATANIA, J., DAIGLE, D. & DIAZ, R. (1996). Decisions to get HIV tested and to accept antiretroviral therapies among gay/bisexual men: implications for secondary prevention efforts. Journal of Acquired Immune Deficiency Syndrome and Human Retrovirology , 11, 151-160.
52. VANABLE, P.A., OSTROW, D.G., MCKIRNAN, D.J., TAYWADITEP, K.J. & HOPE, B.A. (2000). Impact of combination therapies on HIV risk perceptions and sexual risk taking among HIV-positive and HIV-negative gay and bisexual men. Health Psychology, 19, 134-145.
53. WATTERS, J.K. & BIERNACKI, P. (1989). Targeted sampling: options and considerations for the study of hidden populations. Social Problems, 36, 416-430.
54. WEIDLE, P.J., GANEA, C.E., IRWIN, K.L., MCGOWAN, J.P., ERNST, J.A., OLIVO, N. & HOLMBERG, S.D. (1999). Adherence to antiretroviral medications in an inner-city population. Journal of Acquired Immune Deficiency Syndromes, 22, 498-502.